nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC10—Vincristine—muscle cancer	0.0644	0.0763	CbGbCtD
Verapamil—ABCC10—Etoposide—muscle cancer	0.059	0.0699	CbGbCtD
Verapamil—ABCC3—Vincristine—muscle cancer	0.0405	0.048	CbGbCtD
Verapamil—ABCC1—Dactinomycin—muscle cancer	0.0404	0.0478	CbGbCtD
Verapamil—ABCC10—Doxorubicin—muscle cancer	0.0403	0.0477	CbGbCtD
Verapamil—ABCC10—Methotrexate—muscle cancer	0.039	0.0462	CbGbCtD
Verapamil—SLC22A5—Dactinomycin—muscle cancer	0.0384	0.0455	CbGbCtD
Verapamil—ABCC3—Etoposide—muscle cancer	0.0371	0.044	CbGbCtD
Verapamil—ABCB11—Vincristine—muscle cancer	0.035	0.0415	CbGbCtD
Verapamil—ABCG2—Dactinomycin—muscle cancer	0.027	0.032	CbGbCtD
Verapamil—ABCC3—Doxorubicin—muscle cancer	0.0253	0.03	CbGbCtD
Verapamil—ABCC1—Vincristine—muscle cancer	0.0249	0.0295	CbGbCtD
Verapamil—ABCC3—Methotrexate—muscle cancer	0.0245	0.029	CbGbCtD
Verapamil—ABCC1—Etoposide—muscle cancer	0.0228	0.027	CbGbCtD
Verapamil—ABCB11—Doxorubicin—muscle cancer	0.0219	0.0259	CbGbCtD
Verapamil—ABCC4—Methotrexate—muscle cancer	0.0187	0.0222	CbGbCtD
Verapamil—ABCC2—Vincristine—muscle cancer	0.0184	0.0218	CbGbCtD
Verapamil—ABCC2—Etoposide—muscle cancer	0.0169	0.02	CbGbCtD
Verapamil—ABCG2—Vincristine—muscle cancer	0.0166	0.0197	CbGbCtD
Verapamil—ABCC1—Doxorubicin—muscle cancer	0.0155	0.0184	CbGbCtD
Verapamil—ABCG2—Etoposide—muscle cancer	0.0152	0.0181	CbGbCtD
Verapamil—ABCC1—Methotrexate—muscle cancer	0.0151	0.0178	CbGbCtD
Verapamil—CACNA1S—pes—muscle cancer	0.0139	0.193	CbGeAlD
Verapamil—SLCO1A2—Methotrexate—muscle cancer	0.0134	0.0159	CbGbCtD
Verapamil—CYP1A2—Dacarbazine—muscle cancer	0.0129	0.0152	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—muscle cancer	0.0127	0.015	CbGbCtD
Verapamil—CYP3A7—Vincristine—muscle cancer	0.0123	0.0146	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0123	0.0146	CbGbCtD
Verapamil—ABCC2—Doxorubicin—muscle cancer	0.0115	0.0136	CbGbCtD
Verapamil—ABCC2—Methotrexate—muscle cancer	0.0111	0.0132	CbGbCtD
Verapamil—ABCG2—Doxorubicin—muscle cancer	0.0104	0.0123	CbGbCtD
Verapamil—ABCG2—Methotrexate—muscle cancer	0.0101	0.0119	CbGbCtD
Verapamil—ABCB1—Dactinomycin—muscle cancer	0.00974	0.0115	CbGbCtD
Verapamil—CYP3A5—Vincristine—muscle cancer	0.00922	0.0109	CbGbCtD
Verapamil—CYP3A5—Etoposide—muscle cancer	0.00845	0.01	CbGbCtD
Verapamil—CYP2C8—Etoposide—muscle cancer	0.00812	0.00962	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—muscle cancer	0.00731	0.00867	CbGbCtD
Verapamil—CYP1A2—Etoposide—muscle cancer	0.00629	0.00745	CbGbCtD
Verapamil—ABCB1—Vincristine—muscle cancer	0.006	0.00711	CbGbCtD
Verapamil—ABCB1—Etoposide—muscle cancer	0.0055	0.00651	CbGbCtD
Verapamil—ABCB1—Doxorubicin—muscle cancer	0.00375	0.00444	CbGbCtD
Verapamil—ABCB1—Methotrexate—muscle cancer	0.00363	0.0043	CbGbCtD
Verapamil—CYP3A4—Vincristine—muscle cancer	0.00359	0.00426	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—muscle cancer	0.00353	0.00419	CbGbCtD
Verapamil—SLC22A4—larynx—muscle cancer	0.00337	0.0467	CbGeAlD
Verapamil—CYP3A4—Etoposide—muscle cancer	0.00329	0.0039	CbGbCtD
Verapamil—CYP3A4—Doxorubicin—muscle cancer	0.00225	0.00266	CbGbCtD
Verapamil—CACNA1F—head—muscle cancer	0.00162	0.0225	CbGeAlD
Verapamil—Ileus paralytic—Vincristine—muscle cancer	0.00145	0.0301	CcSEcCtD
Verapamil—CACNA1I—testis—muscle cancer	0.00125	0.0174	CbGeAlD
Verapamil—CACNB4—tendon—muscle cancer	0.00125	0.0173	CbGeAlD
Verapamil—CACNB4—vagina—muscle cancer	0.00116	0.016	CbGeAlD
Verapamil—CACNB4—head—muscle cancer	0.00107	0.0148	CbGeAlD
Verapamil—CACNA1S—tendon—muscle cancer	0.00107	0.0148	CbGeAlD
Verapamil—CACNB4—testis—muscle cancer	0.00103	0.0143	CbGeAlD
Verapamil—CACNA1A—head—muscle cancer	0.00102	0.0141	CbGeAlD
Verapamil—CACNA1B—head—muscle cancer	0.000995	0.0138	CbGeAlD
Verapamil—CACNB1—tendon—muscle cancer	0.000995	0.0138	CbGeAlD
Verapamil—CACNA1A—testis—muscle cancer	0.000985	0.0136	CbGeAlD
Verapamil—CACNA1B—testis—muscle cancer	0.000961	0.0133	CbGeAlD
Verapamil—CACNB3—tendon—muscle cancer	0.000954	0.0132	CbGeAlD
Verapamil—Hepatotoxicity—Dactinomycin—muscle cancer	0.00091	0.0189	CcSEcCtD
Verapamil—Paralysis—Vincristine—muscle cancer	0.000904	0.0188	CcSEcCtD
Verapamil—CACNA1H—smooth muscle tissue—muscle cancer	0.000903	0.0125	CbGeAlD
Verapamil—CACNA1G—head—muscle cancer	0.000889	0.0123	CbGeAlD
Verapamil—Ileus—Vincristine—muscle cancer	0.000887	0.0184	CcSEcCtD
Verapamil—CACNB3—vagina—muscle cancer	0.000885	0.0123	CbGeAlD
Verapamil—Nystagmus—Vincristine—muscle cancer	0.000879	0.0183	CcSEcCtD
Verapamil—CACNB1—head—muscle cancer	0.000853	0.0118	CbGeAlD
Verapamil—CACNB1—testis—muscle cancer	0.000824	0.0114	CbGeAlD
Verapamil—CACNB3—head—muscle cancer	0.000818	0.0113	CbGeAlD
Verapamil—CACNB3—testis—muscle cancer	0.00079	0.011	CbGeAlD
Verapamil—CACNB2—cardiac atrium—muscle cancer	0.000735	0.0102	CbGeAlD
Verapamil—CYP2C18—vagina—muscle cancer	0.000705	0.00978	CbGeAlD
Verapamil—CACNA1C—smooth muscle tissue—muscle cancer	0.000688	0.00954	CbGeAlD
Verapamil—Laryngospasm—Etoposide—muscle cancer	0.000682	0.0141	CcSEcCtD
Verapamil—Hepatotoxicity—Etoposide—muscle cancer	0.000659	0.0137	CcSEcCtD
Verapamil—CACNA1D—cardiac atrium—muscle cancer	0.000643	0.00891	CbGeAlD
Verapamil—CACNB2—tendon—muscle cancer	0.000641	0.00889	CbGeAlD
Verapamil—Respiratory failure—Vincristine—muscle cancer	0.00064	0.0133	CcSEcCtD
Verapamil—SLCO1B1—renal system—muscle cancer	0.000635	0.00881	CbGeAlD
Verapamil—ABCB11—testis—muscle cancer	0.000612	0.00849	CbGeAlD
Verapamil—KCNJ11—tendon—muscle cancer	0.000608	0.00843	CbGeAlD
Verapamil—ABCC3—renal system—muscle cancer	0.000603	0.00836	CbGeAlD
Verapamil—ABCC10—renal system—muscle cancer	0.0006	0.00831	CbGeAlD
Verapamil—CACNB2—vagina—muscle cancer	0.000595	0.00825	CbGeAlD
Verapamil—CACNA1C—cardiac atrium—muscle cancer	0.000593	0.00823	CbGeAlD
Verapamil—SCN5A—cardiac atrium—muscle cancer	0.000575	0.00797	CbGeAlD
Verapamil—SLC22A4—renal system—muscle cancer	0.000564	0.00782	CbGeAlD
Verapamil—CACNA1H—testis—muscle cancer	0.000562	0.00779	CbGeAlD
Verapamil—CACNB2—head—muscle cancer	0.000549	0.00762	CbGeAlD
Verapamil—ABCC10—cardiac atrium—muscle cancer	0.000537	0.00745	CbGeAlD
Verapamil—SLC22A1—renal system—muscle cancer	0.000537	0.00744	CbGeAlD
Verapamil—CACNB2—testis—muscle cancer	0.000531	0.00736	CbGeAlD
Verapamil—KCNJ11—head—muscle cancer	0.000521	0.00723	CbGeAlD
Verapamil—Lethargy—Dactinomycin—muscle cancer	0.000521	0.0108	CcSEcCtD
Verapamil—SLCO1A2—renal system—muscle cancer	0.000517	0.00717	CbGeAlD
Verapamil—ABCC4—renal system—muscle cancer	0.000498	0.0069	CbGeAlD
Verapamil—ABCC2—renal system—muscle cancer	0.000482	0.00668	CbGeAlD
Verapamil—CACNA1D—head—muscle cancer	0.00048	0.00666	CbGeAlD
Verapamil—CACNA1C—vagina—muscle cancer	0.00048	0.00665	CbGeAlD
Verapamil—ABCC10—tendon—muscle cancer	0.000468	0.00649	CbGeAlD
Verapamil—SCN5A—vagina—muscle cancer	0.000465	0.00645	CbGeAlD
Verapamil—CACNA1D—testis—muscle cancer	0.000464	0.00643	CbGeAlD
Verapamil—Rash maculo-papular—Etoposide—muscle cancer	0.000462	0.0096	CcSEcCtD
Verapamil—ABCC10—bone marrow—muscle cancer	0.000454	0.00629	CbGeAlD
Verapamil—CACNA1C—head—muscle cancer	0.000443	0.00615	CbGeAlD
Verapamil—SLC22A4—tendon—muscle cancer	0.00044	0.0061	CbGeAlD
Verapamil—Paralysis—Methotrexate—muscle cancer	0.000439	0.0091	CcSEcCtD
Verapamil—ABCC10—vagina—muscle cancer	0.000434	0.00602	CbGeAlD
Verapamil—Cardiac arrest—Vincristine—muscle cancer	0.000434	0.009	CcSEcCtD
Verapamil—SCN5A—head—muscle cancer	0.00043	0.00596	CbGeAlD
Verapamil—CACNA1C—testis—muscle cancer	0.000428	0.00594	CbGeAlD
Verapamil—SLC22A4—bone marrow—muscle cancer	0.000426	0.00591	CbGeAlD
Verapamil—SLC22A4—vagina—muscle cancer	0.000408	0.00566	CbGeAlD
Verapamil—ABCC3—head—muscle cancer	0.000403	0.00559	CbGeAlD
Verapamil—Muscular weakness—Vincristine—muscle cancer	0.000402	0.00835	CcSEcCtD
Verapamil—KCNH2—renal system—muscle cancer	0.000395	0.00547	CbGeAlD
Verapamil—Hepatotoxicity—Methotrexate—muscle cancer	0.000395	0.00819	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00039	0.00809	CcSEcCtD
Verapamil—ABCC3—testis—muscle cancer	0.00039	0.0054	CbGeAlD
Verapamil—SLC22A1—vagina—muscle cancer	0.000389	0.00539	CbGeAlD
Verapamil—ABCC4—tendon—muscle cancer	0.000388	0.00538	CbGeAlD
Verapamil—ABCC10—testis—muscle cancer	0.000388	0.00537	CbGeAlD
Verapamil—ABCC1—cardiac atrium—muscle cancer	0.00038	0.00527	CbGeAlD
Verapamil—Paralysis—Doxorubicin—muscle cancer	0.00038	0.00788	CcSEcCtD
Verapamil—Cardiac failure—Etoposide—muscle cancer	0.000378	0.00785	CcSEcCtD
Verapamil—ABCC4—bone marrow—muscle cancer	0.000376	0.00521	CbGeAlD
Verapamil—ABCC2—tendon—muscle cancer	0.000376	0.00521	CbGeAlD
Verapamil—SLC22A5—renal system—muscle cancer	0.000373	0.00517	CbGeAlD
Verapamil—Ileus—Doxorubicin—muscle cancer	0.000373	0.00774	CcSEcCtD
Verapamil—Petechiae—Methotrexate—muscle cancer	0.00037	0.00769	CcSEcCtD
Verapamil—Nystagmus—Doxorubicin—muscle cancer	0.000369	0.00767	CcSEcCtD
Verapamil—Erectile dysfunction—Vincristine—muscle cancer	0.000363	0.00753	CcSEcCtD
Verapamil—CYP2C8—renal system—muscle cancer	0.000361	0.00501	CbGeAlD
Verapamil—SLC22A1—head—muscle cancer	0.000359	0.00498	CbGeAlD
Verapamil—KCNH2—cardiac atrium—muscle cancer	0.000354	0.0049	CbGeAlD
Verapamil—Hepatitis—Dactinomycin—muscle cancer	0.000353	0.00733	CcSEcCtD
Verapamil—Cardiac arrest—Etoposide—muscle cancer	0.000351	0.00729	CcSEcCtD
Verapamil—Pharyngitis—Dactinomycin—muscle cancer	0.00035	0.00727	CcSEcCtD
Verapamil—Acute coronary syndrome—Vincristine—muscle cancer	0.000346	0.00719	CcSEcCtD
Verapamil—SLCO1A2—head—muscle cancer	0.000346	0.00479	CbGeAlD
Verapamil—Myocardial infarction—Vincristine—muscle cancer	0.000344	0.00715	CcSEcCtD
Verapamil—CYP1A2—renal system—muscle cancer	0.000338	0.00469	CbGeAlD
Verapamil—Sweating—Vincristine—muscle cancer	0.000337	0.00699	CcSEcCtD
Verapamil—SLC6A4—head—muscle cancer	0.000334	0.00463	CbGeAlD
Verapamil—SLCO1A2—testis—muscle cancer	0.000334	0.00463	CbGeAlD
Verapamil—SLC22A5—cardiac atrium—muscle cancer	0.000334	0.00463	CbGeAlD
Verapamil—Erythema multiforme—Dactinomycin—muscle cancer	0.000334	0.00693	CcSEcCtD
Verapamil—ABCC4—head—muscle cancer	0.000333	0.00461	CbGeAlD
Verapamil—Cramp muscle—Etoposide—muscle cancer	0.000333	0.0069	CcSEcCtD
Verapamil—ABCC1—tendon—muscle cancer	0.000331	0.00459	CbGeAlD
Verapamil—Flushing—Dactinomycin—muscle cancer	0.000328	0.0068	CcSEcCtD
Verapamil—CYP3A5—renal system—muscle cancer	0.000326	0.00452	CbGeAlD
Verapamil—CYP2B6—renal system—muscle cancer	0.000324	0.00449	CbGeAlD
Verapamil—Hepatic enzyme increased—Methotrexate—muscle cancer	0.000322	0.00669	CcSEcCtD
Verapamil—ABCC4—testis—muscle cancer	0.000322	0.00446	CbGeAlD
Verapamil—Petechiae—Doxorubicin—muscle cancer	0.000321	0.00666	CcSEcCtD
Verapamil—Bronchospasm—Etoposide—muscle cancer	0.000314	0.00652	CcSEcCtD
Verapamil—Hypoaesthesia—Vincristine—muscle cancer	0.000314	0.00651	CcSEcCtD
Verapamil—Vasculitis—Methotrexate—muscle cancer	0.000312	0.00648	CcSEcCtD
Verapamil—Alopecia—Dactinomycin—muscle cancer	0.000312	0.00647	CcSEcCtD
Verapamil—ABCC2—testis—muscle cancer	0.000311	0.00431	CbGeAlD
Verapamil—Sweating increased—Etoposide—muscle cancer	0.000311	0.00645	CcSEcCtD
Verapamil—Respiratory failure—Methotrexate—muscle cancer	0.00031	0.00644	CcSEcCtD
Verapamil—ABCC1—vagina—muscle cancer	0.000307	0.00426	CbGeAlD
Verapamil—CYP2C19—vagina—muscle cancer	0.0003	0.00416	CbGeAlD
Verapamil—KCNH2—bone marrow—muscle cancer	0.000299	0.00414	CbGeAlD
Verapamil—SLC22A5—tendon—muscle cancer	0.000291	0.00404	CbGeAlD
Verapamil—KCNH2—vagina—muscle cancer	0.000286	0.00396	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000282	0.00586	CcSEcCtD
Verapamil—Acute coronary syndrome—Etoposide—muscle cancer	0.000281	0.00582	CcSEcCtD
Verapamil—Myocardial infarction—Etoposide—muscle cancer	0.000279	0.00579	CcSEcCtD
Verapamil—Alopecia—Vincristine—muscle cancer	0.000279	0.00578	CcSEcCtD
Verapamil—Jaundice—Etoposide—muscle cancer	0.000277	0.00576	CcSEcCtD
Verapamil—Ecchymosis—Methotrexate—muscle cancer	0.000276	0.00572	CcSEcCtD
Verapamil—ABCC1—testis—muscle cancer	0.000274	0.0038	CbGeAlD
Verapamil—Gynaecomastia—Methotrexate—muscle cancer	0.000273	0.00566	CcSEcCtD
Verapamil—Atrioventricular block—Doxorubicin—muscle cancer	0.000272	0.00565	CcSEcCtD
Verapamil—Pulmonary oedema—Methotrexate—muscle cancer	0.000271	0.00563	CcSEcCtD
Verapamil—SLC22A5—vagina—muscle cancer	0.00027	0.00375	CbGeAlD
Verapamil—ABCG2—bone marrow—muscle cancer	0.000266	0.00368	CbGeAlD
Verapamil—KCNH2—head—muscle cancer	0.000264	0.00366	CbGeAlD
Verapamil—Myalgia—Dactinomycin—muscle cancer	0.000262	0.00543	CcSEcCtD
Verapamil—CYP2C8—vagina—muscle cancer	0.000262	0.00363	CbGeAlD
Verapamil—Discomfort—Dactinomycin—muscle cancer	0.000259	0.00537	CcSEcCtD
Verapamil—KCNH2—testis—muscle cancer	0.000255	0.00354	CbGeAlD
Verapamil—ABCG2—vagina—muscle cancer	0.000254	0.00353	CbGeAlD
Verapamil—Hypoaesthesia—Etoposide—muscle cancer	0.000254	0.00528	CcSEcCtD
Verapamil—Agitation—Vincristine—muscle cancer	0.000252	0.00524	CcSEcCtD
Verapamil—Oedema—Dactinomycin—muscle cancer	0.000251	0.00521	CcSEcCtD
Verapamil—Infection—Dactinomycin—muscle cancer	0.000249	0.00517	CcSEcCtD
Verapamil—Vertigo—Vincristine—muscle cancer	0.000247	0.00512	CcSEcCtD
Verapamil—CYP3A4—renal system—muscle cancer	0.000245	0.00339	CbGeAlD
Verapamil—Erythema multiforme—Etoposide—muscle cancer	0.000242	0.00501	CcSEcCtD
Verapamil—SLC22A5—testis—muscle cancer	0.000241	0.00334	CbGeAlD
Verapamil—CYP2D6—renal system—muscle cancer	0.000241	0.00334	CbGeAlD
Verapamil—Rash maculo-papular—Doxorubicin—muscle cancer	0.00024	0.00498	CcSEcCtD
Verapamil—Ecchymosis—Doxorubicin—muscle cancer	0.000239	0.00495	CcSEcCtD
Verapamil—Convulsion—Vincristine—muscle cancer	0.000238	0.00494	CcSEcCtD
Verapamil—Flushing—Etoposide—muscle cancer	0.000237	0.00492	CcSEcCtD
Verapamil—Hypertension—Vincristine—muscle cancer	0.000237	0.00492	CcSEcCtD
Verapamil—CYP3A5—vagina—muscle cancer	0.000236	0.00327	CbGeAlD
Verapamil—Pulmonary oedema—Doxorubicin—muscle cancer	0.000235	0.00488	CcSEcCtD
Verapamil—CYP2B6—vagina—muscle cancer	0.000235	0.00325	CbGeAlD
Verapamil—Myalgia—Vincristine—muscle cancer	0.000234	0.00485	CcSEcCtD
Verapamil—CYP2C8—testis—muscle cancer	0.000233	0.00324	CbGeAlD
Verapamil—ABCB1—embryo—muscle cancer	0.000229	0.00317	CbGeAlD
Verapamil—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000229	0.00474	CcSEcCtD
Verapamil—ABCG2—testis—muscle cancer	0.000227	0.00315	CbGeAlD
Verapamil—Alopecia—Etoposide—muscle cancer	0.000226	0.00469	CcSEcCtD
Verapamil—Cerebrovascular accident—Methotrexate—muscle cancer	0.000226	0.00469	CcSEcCtD
Verapamil—Lethargy—Methotrexate—muscle cancer	0.000226	0.00469	CcSEcCtD
Verapamil—Anaphylactic shock—Vincristine—muscle cancer	0.000224	0.00465	CcSEcCtD
Verapamil—Oedema—Vincristine—muscle cancer	0.000224	0.00465	CcSEcCtD
Verapamil—Infection—Vincristine—muscle cancer	0.000223	0.00462	CcSEcCtD
Verapamil—CYP2B6—head—muscle cancer	0.000217	0.00301	CbGeAlD
Verapamil—Hyperhidrosis—Vincristine—muscle cancer	0.000217	0.0045	CcSEcCtD
Verapamil—Fatigue—Dactinomycin—muscle cancer	0.000216	0.00449	CcSEcCtD
Verapamil—Pain—Dactinomycin—muscle cancer	0.000214	0.00445	CcSEcCtD
Verapamil—Vascular purpura—Doxorubicin—muscle cancer	0.000214	0.00444	CcSEcCtD
Verapamil—Muscle spasms—Etoposide—muscle cancer	0.000214	0.00444	CcSEcCtD
Verapamil—CYP2B6—testis—muscle cancer	0.000209	0.0029	CbGeAlD
Verapamil—Hypotension—Vincristine—muscle cancer	0.000209	0.00435	CcSEcCtD
Verapamil—Feeling abnormal—Dactinomycin—muscle cancer	0.000207	0.00429	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000204	0.00424	CcSEcCtD
Verapamil—Insomnia—Vincristine—muscle cancer	0.000203	0.00421	CcSEcCtD
Verapamil—Paraesthesia—Vincristine—muscle cancer	0.000201	0.00418	CcSEcCtD
Verapamil—Vertigo—Etoposide—muscle cancer	0.0002	0.00415	CcSEcCtD
Verapamil—Purpura—Doxorubicin—muscle cancer	0.000199	0.00413	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—muscle cancer	0.000196	0.00407	CcSEcCtD
Verapamil—Loss of consciousness—Etoposide—muscle cancer	0.000195	0.00406	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000195	0.00406	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—muscle cancer	0.000195	0.00406	CcSEcCtD
Verapamil—Fatigue—Vincristine—muscle cancer	0.000193	0.00401	CcSEcCtD
Verapamil—Convulsion—Etoposide—muscle cancer	0.000193	0.004	CcSEcCtD
Verapamil—Hypertension—Etoposide—muscle cancer	0.000192	0.00399	CcSEcCtD
Verapamil—Pain—Vincristine—muscle cancer	0.000192	0.00398	CcSEcCtD
Verapamil—Constipation—Vincristine—muscle cancer	0.000192	0.00398	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—muscle cancer	0.000192	0.00398	CcSEcCtD
Verapamil—SCN5A—Cardiac Progenitor Differentiation—KIT—muscle cancer	0.000189	0.00533	CbGpPWpGaD
Verapamil—Chest pain—Etoposide—muscle cancer	0.000189	0.00393	CcSEcCtD
Verapamil—Discomfort—Etoposide—muscle cancer	0.000187	0.00388	CcSEcCtD
Verapamil—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.000187	0.00526	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MYOG—muscle cancer	0.000186	0.00525	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—MED12—muscle cancer	0.000185	0.00521	CbGpPWpGaD
Verapamil—Hypersensitivity—Dactinomycin—muscle cancer	0.000185	0.00384	CcSEcCtD
Verapamil—Abdominal discomfort—Methotrexate—muscle cancer	0.000183	0.0038	CcSEcCtD
Verapamil—Confusional state—Etoposide—muscle cancer	0.000183	0.0038	CcSEcCtD
Verapamil—Cardiac arrest—Doxorubicin—muscle cancer	0.000182	0.00378	CcSEcCtD
Verapamil—Anaphylactic shock—Etoposide—muscle cancer	0.000182	0.00377	CcSEcCtD
Verapamil—Infection—Etoposide—muscle cancer	0.00018	0.00374	CcSEcCtD
Verapamil—Asthenia—Dactinomycin—muscle cancer	0.00018	0.00374	CcSEcCtD
Verapamil—ABCC1—S1P1 pathway—VEGFA—muscle cancer	0.000179	0.00503	CbGpPWpGaD
Verapamil—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000178	0.00369	CcSEcCtD
Verapamil—Tachycardia—Etoposide—muscle cancer	0.000177	0.00368	CcSEcCtD
Verapamil—Erectile dysfunction—Methotrexate—muscle cancer	0.000176	0.00366	CcSEcCtD
Verapamil—Hyperhidrosis—Etoposide—muscle cancer	0.000175	0.00364	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000175	0.00363	CcSEcCtD
Verapamil—CACNA1I—Developmental Biology—MED12—muscle cancer	0.000174	0.00489	CbGpPWpGaD
Verapamil—ABCB1—renal system—muscle cancer	0.000173	0.0024	CbGeAlD
Verapamil—Diarrhoea—Dactinomycin—muscle cancer	0.000172	0.00356	CcSEcCtD
Verapamil—Drowsiness—Methotrexate—muscle cancer	0.00017	0.00354	CcSEcCtD
Verapamil—Hypotension—Etoposide—muscle cancer	0.00017	0.00352	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000169	0.00351	CcSEcCtD
Verapamil—Muscular weakness—Doxorubicin—muscle cancer	0.000169	0.00351	CcSEcCtD
Verapamil—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000167	0.0047	CbGpPWpGaD
Verapamil—Influenza—Doxorubicin—muscle cancer	0.000166	0.00344	CcSEcCtD
Verapamil—Hypersensitivity—Vincristine—muscle cancer	0.000165	0.00343	CcSEcCtD
Verapamil—Sweating—Methotrexate—muscle cancer	0.000163	0.00339	CcSEcCtD
Verapamil—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000163	0.00459	CbGpPWpGaD
Verapamil—Paraesthesia—Etoposide—muscle cancer	0.000163	0.00338	CcSEcCtD
Verapamil—ABCC4—Platelet degranulation—IGF2—muscle cancer	0.000162	0.00456	CbGpPWpGaD
Verapamil—Dyspnoea—Etoposide—muscle cancer	0.000162	0.00336	CcSEcCtD
Verapamil—CACNB3—Developmental Biology—MYOD1—muscle cancer	0.000162	0.00455	CbGpPWpGaD
Verapamil—Somnolence—Etoposide—muscle cancer	0.000161	0.00335	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—muscle cancer	0.000161	0.00335	CcSEcCtD
Verapamil—CYP2D6—head—muscle cancer	0.000161	0.00223	CbGeAlD
Verapamil—Asthenia—Vincristine—muscle cancer	0.000161	0.00334	CcSEcCtD
Verapamil—CACNB2—Developmental Biology—MYOG—muscle cancer	0.00016	0.0045	CbGpPWpGaD
Verapamil—Vomiting—Dactinomycin—muscle cancer	0.000159	0.00331	CcSEcCtD
Verapamil—Rash—Dactinomycin—muscle cancer	0.000158	0.00328	CcSEcCtD
Verapamil—CACNB1—Developmental Biology—MYOD1—muscle cancer	0.000157	0.00443	CbGpPWpGaD
Verapamil—Fatigue—Etoposide—muscle cancer	0.000157	0.00325	CcSEcCtD
Verapamil—CYP2D6—testis—muscle cancer	0.000156	0.00216	CbGeAlD
Verapamil—Constipation—Etoposide—muscle cancer	0.000155	0.00322	CcSEcCtD
Verapamil—Pain—Etoposide—muscle cancer	0.000155	0.00322	CcSEcCtD
Verapamil—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.000154	0.00434	CbGpPWpGaD
Verapamil—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000154	0.00319	CcSEcCtD
Verapamil—Diarrhoea—Vincristine—muscle cancer	0.000153	0.00318	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—muscle cancer	0.000153	0.00318	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—muscle cancer	0.000153	0.00317	CcSEcCtD
Verapamil—CYP2C18—Tryptophan metabolism—MDM2—muscle cancer	0.000152	0.00429	CbGpPWpGaD
Verapamil—Pharyngitis—Methotrexate—muscle cancer	0.000152	0.00315	CcSEcCtD
Verapamil—CACNA1D—Developmental Biology—MYOG—muscle cancer	0.000151	0.00426	CbGpPWpGaD
Verapamil—Feeling abnormal—Etoposide—muscle cancer	0.00015	0.0031	CcSEcCtD
Verapamil—Nausea—Dactinomycin—muscle cancer	0.000149	0.00309	CcSEcCtD
Verapamil—Dizziness—Vincristine—muscle cancer	0.000148	0.00308	CcSEcCtD
Verapamil—CACNB3—Developmental Biology—MED12—muscle cancer	0.000148	0.00416	CbGpPWpGaD
Verapamil—Drowsiness—Doxorubicin—muscle cancer	0.000148	0.00306	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—muscle cancer	0.000147	0.00306	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000146	0.00304	CcSEcCtD
Verapamil—Erythema multiforme—Methotrexate—muscle cancer	0.000145	0.003	CcSEcCtD
Verapamil—Urticaria—Etoposide—muscle cancer	0.000144	0.00299	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—muscle cancer	0.000144	0.00299	CcSEcCtD
Verapamil—CACNB1—Developmental Biology—MED12—muscle cancer	0.000144	0.00405	CbGpPWpGaD
Verapamil—Tinnitus—Methotrexate—muscle cancer	0.000143	0.00296	CcSEcCtD
Verapamil—Vomiting—Vincristine—muscle cancer	0.000142	0.00296	CcSEcCtD
Verapamil—Sweating—Doxorubicin—muscle cancer	0.000142	0.00294	CcSEcCtD
Verapamil—Rash—Vincristine—muscle cancer	0.000141	0.00293	CcSEcCtD
Verapamil—Dermatitis—Vincristine—muscle cancer	0.000141	0.00293	CcSEcCtD
Verapamil—Headache—Vincristine—muscle cancer	0.00014	0.00291	CcSEcCtD
Verapamil—CACNA1G—Developmental Biology—MYOD1—muscle cancer	0.00014	0.00394	CbGpPWpGaD
Verapamil—Sinusitis—Doxorubicin—muscle cancer	0.000138	0.00287	CcSEcCtD
Verapamil—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000136	0.00384	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—MYOD1—muscle cancer	0.000136	0.00382	CbGpPWpGaD
Verapamil—Alopecia—Methotrexate—muscle cancer	0.000135	0.00281	CcSEcCtD
Verapamil—CACNA1B—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000135	0.0038	CbGpPWpGaD
Verapamil—Bradycardia—Doxorubicin—muscle cancer	0.000135	0.0028	CcSEcCtD
Verapamil—SCN5A—Developmental Biology—MYOG—muscle cancer	0.000134	0.00378	CbGpPWpGaD
Verapamil—Hypersensitivity—Etoposide—muscle cancer	0.000134	0.00278	CcSEcCtD
Verapamil—Nausea—Vincristine—muscle cancer	0.000133	0.00276	CcSEcCtD
Verapamil—CACNA1C—Developmental Biology—MYOG—muscle cancer	0.000133	0.00374	CbGpPWpGaD
Verapamil—Rhinitis—Doxorubicin—muscle cancer	0.000133	0.00276	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—muscle cancer	0.000133	0.00275	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—muscle cancer	0.000132	0.00274	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—muscle cancer	0.000132	0.00273	CcSEcCtD
Verapamil—ABCB1—bone marrow—muscle cancer	0.000131	0.00182	CbGeAlD
Verapamil—Oedema peripheral—Doxorubicin—muscle cancer	0.000131	0.00271	CcSEcCtD
Verapamil—Asthenia—Etoposide—muscle cancer	0.00013	0.0027	CcSEcCtD
Verapamil—Pruritus—Etoposide—muscle cancer	0.000128	0.00267	CcSEcCtD
Verapamil—CACNA1G—Developmental Biology—MED12—muscle cancer	0.000128	0.00361	CbGpPWpGaD
Verapamil—Visual impairment—Doxorubicin—muscle cancer	0.000128	0.00265	CcSEcCtD
Verapamil—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000126	0.00355	CbGpPWpGaD
Verapamil—Vision blurred—Methotrexate—muscle cancer	0.000126	0.00261	CcSEcCtD
Verapamil—CACNB4—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000126	0.00353	CbGpPWpGaD
Verapamil—ABCB1—vagina—muscle cancer	0.000125	0.00174	CbGeAlD
Verapamil—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000125	0.00353	CbGpPWpGaD
Verapamil—Erythema multiforme—Doxorubicin—muscle cancer	0.000125	0.0026	CcSEcCtD
Verapamil—Diarrhoea—Etoposide—muscle cancer	0.000124	0.00258	CcSEcCtD
Verapamil—CACNA1H—Developmental Biology—MED12—muscle cancer	0.000124	0.00349	CbGpPWpGaD
Verapamil—Tinnitus—Doxorubicin—muscle cancer	0.000124	0.00256	CcSEcCtD
Verapamil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	0.000123	0.00347	CbGpPWpGaD
Verapamil—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000123	0.00346	CbGpPWpGaD
Verapamil—Flushing—Doxorubicin—muscle cancer	0.000123	0.00255	CcSEcCtD
Verapamil—Dizziness—Etoposide—muscle cancer	0.00012	0.00249	CcSEcCtD
Verapamil—Vertigo—Methotrexate—muscle cancer	0.00012	0.00248	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—muscle cancer	0.000117	0.00243	CcSEcCtD
Verapamil—ABCB1—head—muscle cancer	0.000116	0.00161	CbGeAlD
Verapamil—Convulsion—Methotrexate—muscle cancer	0.000115	0.0024	CcSEcCtD
Verapamil—Vomiting—Etoposide—muscle cancer	0.000115	0.0024	CcSEcCtD
Verapamil—CACNA1S—Developmental Biology—MYOD1—muscle cancer	0.000115	0.00324	CbGpPWpGaD
Verapamil—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000115	0.00324	CbGpPWpGaD
Verapamil—Rash—Etoposide—muscle cancer	0.000114	0.00238	CcSEcCtD
Verapamil—Dermatitis—Etoposide—muscle cancer	0.000114	0.00237	CcSEcCtD
Verapamil—Headache—Etoposide—muscle cancer	0.000114	0.00236	CcSEcCtD
Verapamil—Chest pain—Methotrexate—muscle cancer	0.000113	0.00235	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—muscle cancer	0.000113	0.00235	CcSEcCtD
Verapamil—Myalgia—Methotrexate—muscle cancer	0.000113	0.00235	CcSEcCtD
Verapamil—Discomfort—Methotrexate—muscle cancer	0.000112	0.00233	CcSEcCtD
Verapamil—ABCB1—testis—muscle cancer	0.000112	0.00155	CbGeAlD
Verapamil—Muscle spasms—Doxorubicin—muscle cancer	0.000111	0.0023	CcSEcCtD
Verapamil—ABCC3—Fluoropyrimidine Activity—TP53—muscle cancer	0.000111	0.00312	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—FH—muscle cancer	0.000111	0.00312	CbGpPWpGaD
Verapamil—Confusional state—Methotrexate—muscle cancer	0.00011	0.00228	CcSEcCtD
Verapamil—Anaphylactic shock—Methotrexate—muscle cancer	0.000109	0.00226	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—muscle cancer	0.000109	0.00226	CcSEcCtD
Verapamil—Infection—Methotrexate—muscle cancer	0.000108	0.00224	CcSEcCtD
Verapamil—Nausea—Etoposide—muscle cancer	0.000108	0.00224	CcSEcCtD
Verapamil—CACNA1A—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000107	0.00301	CbGpPWpGaD
Verapamil—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000106	0.00299	CbGpPWpGaD
Verapamil—Agitation—Doxorubicin—muscle cancer	0.000106	0.0022	CcSEcCtD
Verapamil—CACNA1S—Developmental Biology—MED12—muscle cancer	0.000105	0.00297	CbGpPWpGaD
Verapamil—Hyperhidrosis—Methotrexate—muscle cancer	0.000105	0.00218	CcSEcCtD
Verapamil—ABCC1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000105	0.00295	CbGpPWpGaD
Verapamil—ABCC4—Fluoropyrimidine Activity—TP53—muscle cancer	0.000104	0.00293	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—FH—muscle cancer	0.000104	0.00293	CbGpPWpGaD
Verapamil—Vertigo—Doxorubicin—muscle cancer	0.000104	0.00215	CcSEcCtD
Verapamil—CACNA1B—Neuronal System—MDM2—muscle cancer	0.000103	0.00291	CbGpPWpGaD
Verapamil—Syncope—Doxorubicin—muscle cancer	0.000103	0.00215	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—muscle cancer	0.000102	0.00212	CcSEcCtD
Verapamil—Hypotension—Methotrexate—muscle cancer	0.000102	0.00211	CcSEcCtD
Verapamil—CACNB4—Developmental Biology—FOXO1—muscle cancer	0.000101	0.00286	CbGpPWpGaD
Verapamil—Loss of consciousness—Doxorubicin—muscle cancer	0.000101	0.0021	CcSEcCtD
Verapamil—CACNB3—Transmission across Chemical Synapses—MDM2—muscle cancer	0.0001	0.00283	CbGpPWpGaD
Verapamil—Convulsion—Doxorubicin—muscle cancer	0.0001	0.00207	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—muscle cancer	9.96e-05	0.00207	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methotrexate—muscle cancer	9.91e-05	0.00206	CcSEcCtD
Verapamil—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	9.88e-05	0.00278	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MYOD1—muscle cancer	9.87e-05	0.00278	CbGpPWpGaD
Verapamil—Insomnia—Methotrexate—muscle cancer	9.83e-05	0.00204	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—muscle cancer	9.82e-05	0.00204	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—muscle cancer	9.82e-05	0.00204	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—muscle cancer	9.82e-05	0.00204	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—muscle cancer	9.76e-05	0.00203	CcSEcCtD
Verapamil—CACNB1—Transmission across Chemical Synapses—MDM2—muscle cancer	9.76e-05	0.00275	CbGpPWpGaD
Verapamil—Discomfort—Doxorubicin—muscle cancer	9.7e-05	0.00201	CcSEcCtD
Verapamil—Dyspnoea—Methotrexate—muscle cancer	9.69e-05	0.00201	CcSEcCtD
Verapamil—Somnolence—Methotrexate—muscle cancer	9.67e-05	0.00201	CcSEcCtD
Verapamil—CACNB4—Neuronal System—MDM2—muscle cancer	9.62e-05	0.00271	CbGpPWpGaD
Verapamil—Dry mouth—Doxorubicin—muscle cancer	9.61e-05	0.00199	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—muscle cancer	9.57e-05	0.00199	CcSEcCtD
Verapamil—CACNA1I—Developmental Biology—FOXO1—muscle cancer	9.54e-05	0.00269	CbGpPWpGaD
Verapamil—Confusional state—Doxorubicin—muscle cancer	9.49e-05	0.00197	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—muscle cancer	9.42e-05	0.00195	CcSEcCtD
Verapamil—Oedema—Doxorubicin—muscle cancer	9.42e-05	0.00195	CcSEcCtD
Verapamil—Fatigue—Methotrexate—muscle cancer	9.37e-05	0.00195	CcSEcCtD
Verapamil—Infection—Doxorubicin—muscle cancer	9.35e-05	0.00194	CcSEcCtD
Verapamil—CACNA1D—Developmental Biology—MYOD1—muscle cancer	9.35e-05	0.00263	CbGpPWpGaD
Verapamil—Pain—Methotrexate—muscle cancer	9.3e-05	0.00193	CcSEcCtD
Verapamil—Shock—Doxorubicin—muscle cancer	9.26e-05	0.00192	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—muscle cancer	9.19e-05	0.00191	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—muscle cancer	9.1e-05	0.00189	CcSEcCtD
Verapamil—CACNB2—Developmental Biology—MED12—muscle cancer	9.03e-05	0.00254	CbGpPWpGaD
Verapamil—Feeling abnormal—Methotrexate—muscle cancer	8.96e-05	0.00186	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—muscle cancer	8.8e-05	0.00183	CcSEcCtD
Verapamil—Urticaria—Methotrexate—muscle cancer	8.64e-05	0.00179	CcSEcCtD
Verapamil—CACNA1S—Alzheimers Disease—TP53—muscle cancer	8.63e-05	0.00243	CbGpPWpGaD
Verapamil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	8.58e-05	0.00178	CcSEcCtD
Verapamil—CACNA1D—Developmental Biology—MED12—muscle cancer	8.55e-05	0.00241	CbGpPWpGaD
Verapamil—Insomnia—Doxorubicin—muscle cancer	8.52e-05	0.00177	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—muscle cancer	8.45e-05	0.00175	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—muscle cancer	8.39e-05	0.00174	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—muscle cancer	8.37e-05	0.00174	CcSEcCtD
Verapamil—SCN5A—Developmental Biology—MYOD1—muscle cancer	8.3e-05	0.00234	CbGpPWpGaD
Verapamil—Dyspepsia—Doxorubicin—muscle cancer	8.29e-05	0.00172	CcSEcCtD
Verapamil—CACNA1C—Developmental Biology—MYOD1—muscle cancer	8.21e-05	0.00231	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—MDM2—muscle cancer	8.18e-05	0.0023	CbGpPWpGaD
Verapamil—Fatigue—Doxorubicin—muscle cancer	8.12e-05	0.00168	CcSEcCtD
Verapamil—CACNB3—Developmental Biology—FOXO1—muscle cancer	8.11e-05	0.00228	CbGpPWpGaD
Verapamil—Constipation—Doxorubicin—muscle cancer	8.05e-05	0.00167	CcSEcCtD
Verapamil—Pain—Doxorubicin—muscle cancer	8.05e-05	0.00167	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—muscle cancer	8.01e-05	0.00166	CcSEcCtD
Verapamil—CACNB1—Developmental Biology—FOXO1—muscle cancer	7.89e-05	0.00222	CbGpPWpGaD
Verapamil—Asthenia—Methotrexate—muscle cancer	7.8e-05	0.00162	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—muscle cancer	7.76e-05	0.00161	CcSEcCtD
Verapamil—Pruritus—Methotrexate—muscle cancer	7.69e-05	0.0016	CcSEcCtD
Verapamil—CACNB3—Neuronal System—MDM2—muscle cancer	7.69e-05	0.00216	CbGpPWpGaD
Verapamil—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	7.64e-05	0.00215	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—ANGPT2—muscle cancer	7.62e-05	0.00214	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MED12—muscle cancer	7.59e-05	0.00214	CbGpPWpGaD
Verapamil—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	7.58e-05	0.00213	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MED12—muscle cancer	7.51e-05	0.00212	CbGpPWpGaD
Verapamil—CACNB1—Neuronal System—MDM2—muscle cancer	7.48e-05	0.00211	CbGpPWpGaD
Verapamil—Urticaria—Doxorubicin—muscle cancer	7.48e-05	0.00155	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—muscle cancer	7.44e-05	0.00154	CcSEcCtD
Verapamil—Dizziness—Methotrexate—muscle cancer	7.19e-05	0.00149	CcSEcCtD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—IGF2—muscle cancer	7.18e-05	0.00202	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—FOXO1—muscle cancer	7.03e-05	0.00198	CbGpPWpGaD
Verapamil—CACNA1D—Alzheimers Disease—TP53—muscle cancer	7e-05	0.00197	CbGpPWpGaD
Verapamil—Hypersensitivity—Doxorubicin—muscle cancer	6.94e-05	0.00144	CcSEcCtD
Verapamil—Vomiting—Methotrexate—muscle cancer	6.91e-05	0.00143	CcSEcCtD
Verapamil—Rash—Methotrexate—muscle cancer	6.86e-05	0.00142	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—muscle cancer	6.85e-05	0.00142	CcSEcCtD
Verapamil—CACNA1H—Developmental Biology—FOXO1—muscle cancer	6.81e-05	0.00192	CbGpPWpGaD
Verapamil—Headache—Methotrexate—muscle cancer	6.81e-05	0.00141	CcSEcCtD
Verapamil—ABCC4—Platelet degranulation—VEGFA—muscle cancer	6.79e-05	0.00191	CbGpPWpGaD
Verapamil—Asthenia—Doxorubicin—muscle cancer	6.76e-05	0.0014	CcSEcCtD
Verapamil—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	6.72e-05	0.00189	CbGpPWpGaD
Verapamil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	6.67e-05	0.00188	CbGpPWpGaD
Verapamil—Pruritus—Doxorubicin—muscle cancer	6.66e-05	0.00138	CcSEcCtD
Verapamil—CACNB4—Axon guidance—VEGFA—muscle cancer	6.48e-05	0.00182	CbGpPWpGaD
Verapamil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	6.47e-05	0.00182	CbGpPWpGaD
Verapamil—Nausea—Methotrexate—muscle cancer	6.46e-05	0.00134	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—muscle cancer	6.44e-05	0.00134	CcSEcCtD
Verapamil—CACNB2—Metabolism—FH—muscle cancer	6.36e-05	0.00179	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.27e-05	0.00177	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—MED12—muscle cancer	6.25e-05	0.00176	CbGpPWpGaD
Verapamil—Dizziness—Doxorubicin—muscle cancer	6.23e-05	0.00129	CcSEcCtD
Verapamil—CACNA1C—Alzheimers Disease—TP53—muscle cancer	6.15e-05	0.00173	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—MDM2—muscle cancer	6.13e-05	0.00173	CbGpPWpGaD
Verapamil—CACNA1I—Axon guidance—VEGFA—muscle cancer	6.09e-05	0.00172	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—FH—muscle cancer	6.06e-05	0.00171	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—FH—muscle cancer	6.02e-05	0.00169	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.01e-05	0.00169	CbGpPWpGaD
Verapamil—Vomiting—Doxorubicin—muscle cancer	5.99e-05	0.00124	CcSEcCtD
Verapamil—Rash—Doxorubicin—muscle cancer	5.94e-05	0.00123	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—muscle cancer	5.93e-05	0.00123	CcSEcCtD
Verapamil—Headache—Doxorubicin—muscle cancer	5.9e-05	0.00122	CcSEcCtD
Verapamil—CACNB3—Metabolism—MED12—muscle cancer	5.88e-05	0.00166	CbGpPWpGaD
Verapamil—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	5.81e-05	0.00164	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—FOXO1—muscle cancer	5.78e-05	0.00163	CbGpPWpGaD
Verapamil—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	5.72e-05	0.00161	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—ENO2—muscle cancer	5.7e-05	0.0016	CbGpPWpGaD
Verapamil—Nausea—Doxorubicin—muscle cancer	5.59e-05	0.00116	CcSEcCtD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	5.46e-05	0.00154	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—ENO2—muscle cancer	5.36e-05	0.00151	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—FH—muscle cancer	5.29e-05	0.00149	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.24e-05	0.00147	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—VEGFA—muscle cancer	5.18e-05	0.00146	CbGpPWpGaD
Verapamil—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	5.1e-05	0.00144	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—VEGFA—muscle cancer	5.04e-05	0.00142	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—FOXO1—muscle cancer	4.96e-05	0.0014	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—FH—muscle cancer	4.94e-05	0.00139	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—FH—muscle cancer	4.87e-05	0.00137	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—VEGFA—muscle cancer	4.78e-05	0.00134	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—FH—muscle cancer	4.74e-05	0.00133	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.71e-05	0.00133	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—MDM2—muscle cancer	4.7e-05	0.00132	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—FOXO1—muscle cancer	4.69e-05	0.00132	CbGpPWpGaD
Verapamil—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	4.65e-05	0.00131	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—VEGFA—muscle cancer	4.63e-05	0.0013	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—VEGFA—muscle cancer	4.62e-05	0.0013	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—VEGFA—muscle cancer	4.49e-05	0.00126	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—MDM2—muscle cancer	4.48e-05	0.00126	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.48e-05	0.00126	CbGpPWpGaD
Verapamil—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	4.41e-05	0.00124	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—VEGFA—muscle cancer	4.35e-05	0.00122	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—VEGFA—muscle cancer	4.35e-05	0.00122	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	4.25e-05	0.0012	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—VEGFA—muscle cancer	4.17e-05	0.00117	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—FOXO1—muscle cancer	4.17e-05	0.00117	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—FH—muscle cancer	4.13e-05	0.00116	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—FOXO1—muscle cancer	4.12e-05	0.00116	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	3.99e-05	0.00112	CbGpPWpGaD
Verapamil—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	3.98e-05	0.00112	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—MDM2—muscle cancer	3.83e-05	0.00108	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—FH—muscle cancer	3.71e-05	0.00105	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—IGF2—muscle cancer	3.7e-05	0.00104	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—VEGFA—muscle cancer	3.7e-05	0.00104	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—VEGFA—muscle cancer	3.69e-05	0.00104	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—VEGFA—muscle cancer	3.6e-05	0.00101	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—MED12—muscle cancer	3.59e-05	0.00101	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—FH—muscle cancer	3.53e-05	0.000993	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—MED12—muscle cancer	3.43e-05	0.000965	CbGpPWpGaD
Verapamil—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	3.4e-05	0.000958	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—MED12—muscle cancer	3.4e-05	0.000957	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	3.35e-05	0.000942	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ENO2—muscle cancer	3.27e-05	0.000922	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—FH—muscle cancer	3.27e-05	0.00092	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—FH—muscle cancer	3.24e-05	0.000912	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—VEGFA—muscle cancer	3.21e-05	0.000902	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—VEGFA—muscle cancer	3.16e-05	0.000891	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	3.14e-05	0.000884	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ENO2—muscle cancer	3.12e-05	0.000879	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—VEGFA—muscle cancer	3.1e-05	0.000874	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ENO2—muscle cancer	3.1e-05	0.000873	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—FH—muscle cancer	3.01e-05	0.000848	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	3.01e-05	0.000848	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—VEGFA—muscle cancer	3e-05	0.000844	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—MED12—muscle cancer	2.99e-05	0.000841	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—MDM2—muscle cancer	2.91e-05	0.000818	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—MED12—muscle cancer	2.79e-05	0.000786	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—MED12—muscle cancer	2.75e-05	0.000775	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ENO2—muscle cancer	2.72e-05	0.000767	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—VEGFA—muscle cancer	2.72e-05	0.000766	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—MED12—muscle cancer	2.68e-05	0.000754	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—VEGFA—muscle cancer	2.66e-05	0.000749	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—VEGFA—muscle cancer	2.63e-05	0.000742	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—VEGFA—muscle cancer	2.63e-05	0.000741	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.57e-05	0.000724	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—muscle cancer	2.57e-05	0.000724	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ENO2—muscle cancer	2.55e-05	0.000717	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ENO2—muscle cancer	2.51e-05	0.000706	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ENO2—muscle cancer	2.44e-05	0.000687	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—FH—muscle cancer	2.4e-05	0.000674	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—FH—muscle cancer	2.34e-05	0.000659	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—MED12—muscle cancer	2.33e-05	0.000656	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.3e-05	0.000646	CbGpPWpGaD
Verapamil—ABCC1—Disease—ENO2—muscle cancer	2.28e-05	0.000643	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—VEGFA—muscle cancer	2.26e-05	0.000636	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—MDM2—muscle cancer	2.23e-05	0.000627	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—VEGFA—muscle cancer	2.14e-05	0.000602	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ENO2—muscle cancer	2.13e-05	0.000598	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—MED12—muscle cancer	2.1e-05	0.000591	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.09e-05	0.000589	CbGpPWpGaD
Verapamil—ABCC1—Disease—HMGA1—muscle cancer	2.08e-05	0.000584	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—FH—muscle cancer	2.03e-05	0.000571	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—MED12—muscle cancer	1.99e-05	0.000561	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.99e-05	0.000561	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PTGS2—muscle cancer	1.99e-05	0.000559	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ENO2—muscle cancer	1.91e-05	0.000539	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.91e-05	0.000537	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—VEGFA—muscle cancer	1.9e-05	0.000535	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—VEGFA—muscle cancer	1.88e-05	0.000529	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PTGS2—muscle cancer	1.87e-05	0.000526	CbGpPWpGaD
Verapamil—ABCC1—Disease—FOXO4—muscle cancer	1.86e-05	0.000524	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—MED12—muscle cancer	1.85e-05	0.00052	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—MED12—muscle cancer	1.83e-05	0.000515	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ENO2—muscle cancer	1.82e-05	0.000512	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—FH—muscle cancer	1.81e-05	0.00051	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.79e-05	0.000504	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.77e-05	0.000498	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—FH—muscle cancer	1.77e-05	0.000497	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	1.7e-05	0.00048	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—MED12—muscle cancer	1.7e-05	0.000479	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ENO2—muscle cancer	1.68e-05	0.000474	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ENO2—muscle cancer	1.67e-05	0.00047	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—FH—muscle cancer	1.66e-05	0.000469	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.66e-05	0.000468	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—FH—muscle cancer	1.65e-05	0.000465	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VEGFA—muscle cancer	1.55e-05	0.000437	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ENO2—muscle cancer	1.55e-05	0.000437	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.5e-05	0.000421	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.42e-05	0.0004	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—FH—muscle cancer	1.41e-05	0.000397	CbGpPWpGaD
Verapamil—ABCC1—Disease—FOXO1—muscle cancer	1.38e-05	0.000387	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—MED12—muscle cancer	1.35e-05	0.000381	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.34e-05	0.000378	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—MED12—muscle cancer	1.32e-05	0.000372	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ENO2—muscle cancer	1.23e-05	0.000347	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ENO2—muscle cancer	1.21e-05	0.00034	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—muscle cancer	1.17e-05	0.00033	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MED12—muscle cancer	1.15e-05	0.000323	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTGS2—muscle cancer	1.14e-05	0.000321	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—FH—muscle cancer	1.09e-05	0.000306	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTGS2—muscle cancer	1.09e-05	0.000306	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTGS2—muscle cancer	1.08e-05	0.000304	CbGpPWpGaD
Verapamil—ABCC1—Disease—KIT—muscle cancer	1.05e-05	0.000295	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ENO2—muscle cancer	1.04e-05	0.000294	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MED12—muscle cancer	1.02e-05	0.000288	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.01e-05	0.000286	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MED12—muscle cancer	9.98e-06	0.000281	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—muscle cancer	9.49e-06	0.000267	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MED12—muscle cancer	9.41e-06	0.000265	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MED12—muscle cancer	9.32e-06	0.000263	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ENO2—muscle cancer	9.32e-06	0.000262	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ENO2—muscle cancer	9.1e-06	0.000256	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—muscle cancer	8.87e-06	0.00025	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—muscle cancer	8.74e-06	0.000246	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ENO2—muscle cancer	8.58e-06	0.000241	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—muscle cancer	8.5e-06	0.000239	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ENO2—muscle cancer	8.5e-06	0.000239	CbGpPWpGaD
Verapamil—ABCC1—Disease—MDM2—muscle cancer	8.25e-06	0.000232	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.17e-06	0.00023	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MED12—muscle cancer	7.97e-06	0.000224	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—muscle cancer	7.96e-06	0.000224	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—muscle cancer	7.4e-06	0.000208	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.29e-06	0.000205	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ENO2—muscle cancer	7.26e-06	0.000205	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—muscle cancer	6.66e-06	0.000188	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.65e-06	0.000187	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—muscle cancer	6.33e-06	0.000178	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MED12—muscle cancer	6.15e-06	0.000173	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—muscle cancer	5.86e-06	0.000165	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—muscle cancer	5.81e-06	0.000164	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.68e-06	0.00016	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ENO2—muscle cancer	5.61e-06	0.000158	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—muscle cancer	5.41e-06	0.000152	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—muscle cancer	4.3e-06	0.000121	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—muscle cancer	4.2e-06	0.000118	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—muscle cancer	3.64e-06	0.000102	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—muscle cancer	3.25e-06	9.14e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—muscle cancer	3.17e-06	8.92e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—muscle cancer	2.99e-06	8.41e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—muscle cancer	2.96e-06	8.34e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—muscle cancer	2.53e-06	7.12e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—muscle cancer	1.95e-06	5.5e-05	CbGpPWpGaD
